ALNY Alnylam Pharmaceuticals, Inc.

147.82USD-1.06%Mkt Cap: 19.80B USDP/E: 7.47

Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally. The company offers ONPATTRO for h…